These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1031488)

  • 1. Myocardial metabolism and performance during sodium salicylate infusion in dogs.
    Vik-Mo H; Mjös OD
    Scand J Clin Lab Invest; 1976 Dec; 36(8):763-9. PubMed ID: 1031488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute effects of p-chlorophenoxyisobutyrate on myocardial metabolism and performance in dogs.
    Mjøs OD; Vik-Mo H
    Arzneimittelforschung; 1981; 31(11):1889-91. PubMed ID: 7198470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of myocardial ischaemia and antilipolytic agents on lipolysis and fatty acid metabolism in the in situ dog heart.
    Vik-Mo H; Riemersma RA; Mjøs OD; Oliver MF
    Scand J Clin Lab Invest; 1979 Oct; 39(6):559-68. PubMed ID: 531484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of sodium salicylate on plasma insulin concentration and fatty acid turnover in dogs.
    Vik-Mo H; Hove K; Mjøs OD
    Acta Physiol Scand; 1978 Jun; 103(2):113-9. PubMed ID: 676763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of sodium salicylate and acetylsalicylic acid on epicardial ST-segment elevation during coronary artery occlusion in dogs.
    Vik-Mo H; Mjøs OD
    Scand J Clin Lab Invest; 1977 Jun; 37(4):287-94. PubMed ID: 616055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms for inhibition of free fatty acid mobilization by nicotinic acid and sodium salicylate in canine subcutaneous adipose tissue in situ.
    Vik-Mo H; Mjøs OD
    Scand J Clin Lab Invest; 1978 May; 38(3):209-16. PubMed ID: 663543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute effects of the coronary vasodilator carbocromen on myocardial oxygen consumption, substrate uptake and mechanical performance in intact dogs.
    Vik-Mo H; Mjøs OD; Smiseth O; Riemersma RA; Oliver MF
    Arzneimittelforschung; 1981; 31(7):1088-91. PubMed ID: 7196756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of fatty acid metabolism alters myocardial high-energy phosphates in vivo.
    Schwartz GG; Greyson C; Wisneski JA; Garcia J
    Am J Physiol; 1994 Jul; 267(1 Pt 2):H224-31. PubMed ID: 8048588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inosine causing insulin release and increased myocardial uptake of carbohydrates relative to free fatty acids in dogs.
    Smiseth OA; Gunnes P; Sand T; Mjøs OD
    Clin Physiol; 1989 Feb; 9(1):27-38. PubMed ID: 2650958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of free fatty acids on myocardial function and oxygen consumption in intact dogs.
    Mjos OD
    J Clin Invest; 1971 Jul; 50(7):1386-9. PubMed ID: 5090055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial metabolism during pentobarbital anesthesia in dogs.
    Durham BC; Miller HI
    Anesthesiology; 1975 Apr; 42(4):464-70. PubMed ID: 1119713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of free fatty acids on myocardial oxygen consumption during atrial pacing and catecholamine infusion in man.
    Simonsen S; Kjekshus JK
    Circulation; 1978 Sep; 58(3 Pt 1):484-91. PubMed ID: 679439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of coronary blood flow during acute coronary occlusion in dogs. Effect of nicotinic acid and sodium salicylate.
    Vik-Mo H
    Scand J Clin Lab Invest; 1977 Dec; 37(8):697-703. PubMed ID: 601512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of p-chlorophenoxyisobutyrate on myocardial free fatty acid extraction, ventricular blood flow, and epicardial ST-segment elevation during coronary occlusion in dogs.
    Mjos OD; Miller NE; Riemersma RA; Oliver MF
    Circulation; 1976 Mar; 53(3):494-500. PubMed ID: 1248082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation by insulin of myocardial glucose and fatty acid metabolism in the conscious dog.
    Barrett EJ; Schwartz RG; Francis CK; Zaret BL
    J Clin Invest; 1984 Sep; 74(3):1073-9. PubMed ID: 6381537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effects of the D(-)isomer of 3-hydroxybutyrate on cardiac non-esterified fatty acid uptake and oxygen demand induced by norepinephrine in the intact dog.
    Lammerant J; Huynh-Thu T; Kolanowski J
    J Mol Cell Cardiol; 1985 Apr; 17(4):421-33. PubMed ID: 3894678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of acylcarnitine-transferase blocking agent sodium 2[5-(4-chlorophenyl)-pentyl]-oxirane-2-carboxylate (POCA) on cardiodynamics and myocardial metabolism in dogs.
    Seitelberger R; Kraupp O; Beck A; Bacher S; Raberger G
    J Cardiovasc Pharmacol; 1984; 6(5):902-8. PubMed ID: 6209498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of inhibition of lipolysis on myocardial oxygen consumption in the presence of isoproterenol.
    Mjos OD
    J Clin Invest; 1971 Sep; 50(9):1869-73. PubMed ID: 5564394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in myocardial substrate utilisation and protection of ischemic stressed myocardium by oxfenicine [(S)-4-hydroxyphenylglycine].
    Korb H; Hoeft A; Hunneman DH; Schraeder R; Wolpers HG; Wober W; Hellige G
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Aug; 327(1):70-4. PubMed ID: 6493353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of isoproterenol infusion on the myocardial uptake of fatty acids and other substrates in lambs with an aortopulmonary shunt.
    Gratama JW; Meuzelaar JJ; Dalinghaus M; Zijlstra WG; Kuipers JR
    Pediatr Res; 1996 Jan; 39(1):98-104. PubMed ID: 8825392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.